Here are the dates when blood spot takers need to start offering parents and carers severe combined immunodeficiency (SCID) screening as part of an evaluation in England.
Liz is clinical projects co-ordinator for severe combined immunodeficiency (SCID), for the NHS Newborn Blood Spot Screening Programme.
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is now scheduled to start from September 2021.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021